Next |
home / stock / rgls / rgls message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: $RGLS 35% v1,4M c1.22 f16,840M H1.3499 ML.76 RL.88 | znewcar1 | investorshangout | 04/13/2023 9:17:51 PM |
I took a much larger position after $RGLS | jimmy667 | investorshub | 09/15/2022 2:28:08 AM |
Hi Jimmy, yes I agree. Investors starting to | subslover | investorshub | 09/14/2022 8:26:12 AM |
very strong clinical science | jimmy667 | investorshub | 09/14/2022 5:08:59 AM |
Very strong today! | subslover | investorshub | 09/12/2022 1:47:25 PM |
Not good news Friday after 4PM. Still | kzivann | investorshub | 07/15/2022 8:48:30 PM |
Interesting, PPS didn't drop after R/S. Trading | kzivann | investorshub | 06/30/2022 2:01:04 PM |
R/S 10 = 1. less than expected. | kzivann | investorshub | 06/28/2022 7:55:49 AM |
News: Regulus Therapeutics Announces Receipt of FDA | jedijazz | investorshub | 06/21/2022 1:55:24 PM |
Good news on FDA orphan drug, | kzivann | investorshub | 06/21/2022 12:37:55 PM |
About to pop | Triple nickle | investorshub | 05/27/2022 3:34:38 PM |
Another nice move. | kzivann | investorshub | 05/27/2022 2:37:15 PM |
Lol! I'm not in, never been, but I'm | mplscubfan | investorshub | 05/12/2022 4:05:53 AM |
Anything these days for this company $IMO was | ZZZ888 | investorshub | 05/12/2022 2:32:55 AM |
#DDAmanda Chart on: $RGLS : | Zardiw | investorshub | 05/12/2022 12:25:46 AM |
znewcar1: RGLS 54% v58,6M c.266 f146M H.325 | znewcar1 | investorshangout | 05/11/2022 8:05:38 PM |
UP 80% on this little news. Holding | kzivann | investorshub | 05/11/2022 5:34:50 PM |
It's not even news. They accepted the application. | mplscubfan | investorshub | 05/11/2022 4:58:23 PM |
Finally a little good news!!!! Lets go!!!!! | ZZZ888 | investorshub | 05/11/2022 4:52:15 PM |
$pop$... 50% | kzivann | investorshub | 05/11/2022 3:08:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Regulus Therapeutics Inc. Company Name:
RGLS Stock Symbol:
NASDAQ Market:
Regulus Therapeutics Inc. Website:
Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer PR Newswire SAN DIEGO , May 16, 2024 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of inn...
Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates PR Newswire Initiated the fourth cohort of patients in the Phase 1b multiple-ascending dose (MAD) clinical trial of RGLS8429 for the treatment of autosomal dominant polycystic kidney disea...